With ongoing discussions about the efficacy of cardiovascular devices, it’s crucial to highlight the advancements in post-market surveillance. Recent studies underscore the importance of collecting real-world data to ensure ongoing safety and effectiveness, especially for devices like pacemakers and stents. I’d love to hear your thoughts on how we can further improve monitoring practices in our industry.